
Santen Pharmaceutical Co Ltd
TSE:4536

Dividends
Dividend Yield
Santen Pharmaceutical Co Ltd
Current Yield | |
Min Yield | |
Max Yield | |
Average Yield | |
Median Yield |
Dividend Per Share
Santen Pharmaceutical Co Ltd

Payout Ratio
Santen Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Santen Pharmaceutical Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Santen Pharmaceutical Co Ltd
Average Annual Return | -3.52% |
Standard Deviation of Annual Returns | 28.65% |
Max Drawdown | -56% |
Market Capitalization | 495.3B JPY |
Shares Outstanding | 342 040 000 |
Percentage of Shares Shorted |
N/A
|
Stock Splits
Santen Pharmaceutical Co Ltd's latest stock split occurred on Mar 27, 2015
The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.
Before the split, Santen Pharmaceutical Co Ltd traded at 8720 per share. Afterward, the share price was about 1586.5641.
The adjusted shares began trading on Mar 27, 2015. This was the only stock split in Santen Pharmaceutical Co Ltd's history.